Idioma:

Low blood zinc concentrations in patients with poor clinical outcome during SARS-CoV-2 infection: is there a need to supplement with zinc COVID-19 patients?

Dubourg, Grégory ; Lagier, Jean-Christophe ; Brouqui, Philippe ; Casalta, Jean-Paul ; Jacomo, Véronique ; La Scola, Bernard ; Rolain, Jean-Marc ; Raoult, Didier

Journal of microbiology, immunology and infection, 2021-10, Vol.54 (5), p.997-1000 [Periódico revisado por pares]

Texto completo disponível

Citações Citado por

Título:
Low blood zinc concentrations in patients with poor clinical outcome during SARS-CoV-2 infection: is there a need to supplement with zinc COVID-19 patients?
Autor: Dubourg, Grégory ; Lagier, Jean-Christophe ; Brouqui, Philippe ; Casalta, Jean-Paul ; Jacomo, Véronique ; La Scola, Bernard ; Rolain, Jean-Marc ; Raoult, Didier
Assuntos: Azithromycin ; Bacteriology ; Cardiology and cardiovascular system ; Chloroquine ; Clinical outcome ; Emerging diseases ; Human health and pathology ; Infectious diseases ; Life Sciences ; Microbiology and Parasitology ; Parasitology ; SARS-COV-2 ; Severe ; Short Communication ; Virology ; Zinc
É parte de: Journal of microbiology, immunology and infection, 2021-10, Vol.54 (5), p.997-1000
Notas: ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
PMCID: PMC7881284
Descrição: Among 275 patients with COVID-19, we found that median blood zinc level was significantly lower in patients with poor clinical outcome (N = 75) as compared to patients with good clinical outcome (N = 200) (840 μg/L versus 970 μg/L; p < 0.0001), suggesting that zinc supplementation could be useful for patients with severe COVID-19.
Editor: England: Elsevier B.V
Idioma: Inglês

Links

Voltar para lista de resultados

Anterior Resultado 2 Avançar Ir para próxima página